Ochre Bio (Series A)
Funding Details
Awarder
Gaingels
Date Award
May 24, 2024
Vertical
Healthcare and Biotech
Funding URL
View Funding Page
Valuation
$94,000,000
Company Info
Founders
Jack O'Meara, Quin Wills
Market
Healthcare & Wellness
Coinvestors
LifeForce Capital Fund II,Khosla Ventures
Company Description

Genomic medicines to rejuvenate fatty donor livers before transplant. Ochre Bio is a biotechnology company that develops and builds a deep phenotyping platform to rejuvenate transplant livers.

Links
WebsiteCrunchbaseLinkedInTwitter
Back to HomeBack to Healthcare and Biotech DealsView Funding Announcement